Newsletter | August 8, 2024

08.08.24 -- The Biosimilars Forum Supports House Committee Probe Into The PBM Monopoly

SPONSOR

The Festival of Biologics Basel is Europe’s largest biologics conference and exhibition. The event is for the leaders of the world's biologic drug developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. Join us in Basel for 2024! Book your ticket now

FEATURED EDITORIAL

Is Your Lab Ready For A LIMS Implementation?

Deploying a laboratory information management system (LIMS) can boost your quality control lab's productivity, but how are you going about it? This article shares key steps and considerations for setting up your physical lab, controlling inventory, and more.

FDA Finalizes Guidance About Delaying, Denying, Limiting, Or Refusing An Inspection

The FDA has finalized a guidance on the circumstances that constitute delaying, denying, limiting, or refusing a drug or device inspection. The agency also provides reasons that may cause drugs or devices to be adulterated under the FD&C Act.

INDUSTRY INSIGHTS

High Power Mixing At Large Scale: The Xcellerex Magnetic Mixer System

Explore the advantages of 2000 and 3000 L single-use mixing systems and experimental results demonstrating their capacity to deliver high power at large scales and flexibility for use at lower volumes.

Leveraging Autoinjector Innovation To De-Risk Biosimilar Development

Discover how a biopharmaceutical company can de-risk the launch process by choosing a suitable autoinjector technology and partner.

NEWS HEADLINES

The Biosimilars Forum Supports House Committee On Oversight & Accountability Probe Into The PBM Monopoly

Dr. Reddy's Receives Positive CHMP Opinion From European Medicines Agency For Its Proposed Rituximab Biosimilar

Formycon & Fresenius Kabi Receive Positive CHMP Opinion For FYB202 (Ustekinumab), A Biosimilar Candidate To Stelara

European Medicines Agency (EMA) Approves Bio-Thera Solutions' BAT1706 (Avzivi, bevacizumab), A Biosimilar Referencing Avastin

Prestige Biopharma's Herceptin Biosimilar Tuznue Receives Positive CHMP Opinion From The EMA

Health Canada Approves Celltrion's Steqeyma, A Biosimilar To Stelara (ustekinumab) For The Treatment Of Multiple Chronic Inflammatory Conditions

HANQUYOU Launched For 4 Years With International Quality Recognized Worldwide

SOLUTIONS

Valor Glass: The Future Of Glass Packaging Is Here

Combining Scientific Knowledge And Advanced Technology